| 영문 | interstitial therapy | 한글 | 근접치료 |
|---|---|---|---|
| 설명 | 주로 종양의 치료를 목적으로 하여 인체 조직내에 방사선 물질을 삽입하여 방사선을 조사하는 치료법이다. Brachytherapy라고도 한다. |
||
| 영문 | symptomatic therapy | 한글 | 대증요법 |
|---|---|---|---|
| 설명 | 병의 원인을 찾아 없애기 곤란한 상황에서, 겉으로 나타난 병의 증상에 대응하여 처치를 하는 치료법. 열이 높을 때에 얼음주머니를 대거나 해열제를 써서 열을 내리게 하는 따위가 이에 속한다. |
||
| 영문 | radiation therapy | 한글 | 방사선요법 |
|---|---|---|---|
| 설명 | X선, γ선의 전자방사선이나 전자선, 양자선, 중성자선 등의 입자방사선을 이용해, 주로 악성 종양 치료를 목적으로 하는 치료법이다. 암세포가 주위의 정상세포보다도 방사선 감수성이 높은 점을 이용하여, 정상세포의 손상을 가능한 한 최소로 억제하면서 암세포를 파괴한다. 사용되는 방사선에는 밀봉소선원에서 나오는 γ선, 직선가속기에서 얻어지는 고에너지 X선과 전자선, 텔레코발트장치에 의한 60Co의 γ선과, 베타트론에 의한 전자선, 사이크로트론에서 얻어지는 양자선, 중성자선 등이 있다. |
||
| 영문 | radiation therapy | 한글 | 방사선치료 |
|---|---|---|---|
| 설명 | 방사선의 살균효과나 세포를 죽이는 효과를 치료에 이용하는 방법으로, 좁은 의미로 암의 방사선치료를 의미한다. 암에 대한 방사선치료는 암세포를 죽이는데 효과가 큰 베타선을 주로 사용한다. 하지만, 이런 방사선치료는 정상세포에도 큰 영향을 끼쳐 이에 따른 기능의 장애를 가져올 수 있다. 따라서 방사선치료에 있어서는 단지 그 암세포에 대한 작용뿐만 아니라, 정상세포에 대한 작용도 고려하여 시행한다. |
||
| 영문 | speech therapy | 한글 | 언어치료 |
|---|---|---|---|
| 설명 | 말을 정확하게 발음할 수 없거나 더듬는 환자에게 발음, 대화 따위의 훈련을 전문적으로 행하는 치료법. |
||
| PT | pain threshold; parathormone; parathyroid; paroxysmal tachycardia; part time; patient; pericardial t... |
|---|---|
| FENa, FeNa | Fractional Excretion of Sodium ; Volume의 개념을 제거하여 좀 더 정확한 신장의 농축 능력을 평가, &n... |
| TPC | thromboplastic plasma component; thyroid papillary carcinoma; total patient care; total plasma catec... |
| AART | American Association for Rehabilitation Therapy; American Association for Respiratory Therapy |
| ACT | achievement through counseling and treatment; actin; actinomycin; activated clotting time; advanced ... |
| plasma | <haematology> Acellular fluid in which blood cells are suspended. Serum obtained by defibrinating plasma (plasma derived serum) lacks platelet released factors and is less suitable to support the growth of cells in culture. (13 Oct 1997) |
|---|---|
| plasma accelerator globulin | <chemical> Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor v accomplishes this by forming a complex with factor xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor v leads to owren's disease. Chemical name: Blood-coagulation factor V (12 Dec 1998) |
| plasma albumin | <protein> The serum level of the low molecular protein albumin. Albumin, produced by the liver, plays an important role in maintaining plasma oncotic pressure. Normal serum albumin should be 3.5-5.0 grams per decilitre. Low serum albumin can be found in cases of liver disease and malnutrition. (27 Sep 1997) |
| plasma cell | <haematology> A terminally differentiated antibody forming and usually antibody secreting, cell of the B-cell lineage. (18 Nov 1997) |
| plasma cell balanitis | Benign circumscribed balanitis characterised microscopically by subepithelial plasma cell infiltration and clinically by small erythematous papular lesions. Synonym: balanitis circumscripta plasmacellularis, balanitis of Zoon, Zoon's erythroplasia. (05 Mar 2000) |
| plasma cell dyscrasia | A diverse group of diseases characterised by the proliferation of a single clone of cells producing a monoclonal immunoglobulin or immunoglobulin fragment (a serum M component). The cells usually have plasma cell morphology, but may have lymphocytic or lymphoplasmacytic morphology. This group includes multiple myeloma, Waldenstrom's macroglobulinaemia, the heavy chain disease, benign monoclonal gammopathy, and immunocytic amyloidosis. (05 Mar 2000) |
| plasma cell gingivitis | Intense hyperaemic oedema and inflammation of the gingiva resulting from a hypersensitivity reaction. A dense plasma cell infiltrate is seen in the lamina propria. Synonym: atypical gingivitis. (05 Mar 2000) |
| plasma cell hepatitis | <pathology> A type of chronic active hepatitis that results from circulating auto-antibodies and chronic inflammation of the liver. Symptoms are those of chronic active hepatitis. (27 Sep 1997) |
| plasma cell leukaemia | An unusual disease characterised by leukocytosis and other signs and symptoms that are suggestive of leukaemia, in association with diffuse infiltrations and aggregates of plasma cells in the spleen, liver, bone marrow, and lymph nodes, and the presence of considerable numbers of plasma cells in the circulating blood; the total number of leukocytes in the latter may range from normal levels to 80,000 or 90,000 per cu mm, and 5 to 90% may be plasma cells; multiple myelomas are observed in some examples of plasma cell leukaemia, but discrete nodules are not formed in bone. Although there are other clinicopathologic differences in the two conditions, they may be phases of the same basic process. (05 Mar 2000) |
| plasma cell mastitis | A condition of the breasts characterised by tumourlike indurated masses containing numerous plasma cells, usually resulting from mammary duct ectasia; although clinically resembling malignant disease (attachment to skin and enlargement of axillary lymph nodes), it is not neoplastic. (05 Mar 2000) |
| plasma cell myeloma | Cells resemble mature or immature plasma cells with nuclei that appear cleaved or resemble immunoblasts. The tumour cells are CD19- , CD20- , CD22- and SIg- , but are also cIg+ and CD38+. The Ig heavy and light chain genes can be translocated or deleted. These neoplasms are often disseminated BM tumours of adults and progress to multiple myeloma. (05 Mar 2000) |
| plasma cells | Special white blood cells that produce antibodies. (12 Dec 1998) |
| plasma containment | <physics> In physics experiments or nuclear fusion experiments, operation is intended to prevent, in an effective and sufficiently prolonged manner, the particles of a plasma from striking the walls of the container in which this plasma is produced. Plasma confinement is a fundamental requirement for obtaining net energy from a fusion plasma. The reason is that scattering (hence diffusion) is at least an order of magnitude more probable than fusion reactions. Hence, without confinement, the plasma fuel would disperse before enough fusion reactions could take place. (31 Dec 1997) |
| plasma exchange | Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (ppf), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions. (12 Dec 1998) |
| plasma expander | Artificial plasma extender. (18 Nov 1997) |